| Mature dendritic cells pulsed with exosomes stimulate efficient cytotoxic T‐lymphocyte responses and antitumour immunity S Hao, O Bai, F Li, J Yuan, S Laferte, J Xiang Immunology 120 (1), 90-102, 2007 | 307 | 2007 |
| HER2-directed therapy: current treatment options for HER2-positive breast cancer S Ahmed, A Sami, J Xiang Breast cancer 22, 101-116, 2015 | 244 | 2015 |
| Efficient antitumor immunity derived from maturation of dendritic cells that had phagocytosed apoptotic/necrotic tumor cells Z Chen, T Moyana, A Saxena, R Warrington, Z Jia, J Xiang International journal of cancer 93 (4), 539-548, 2001 | 216 | 2001 |
| A new dynamic model of CD8+ T effector cell responses via CD4+ T helper-antigen-presenting cells J Xiang, H Huang, Y Liu The Journal of Immunology 174 (12), 7497-7505, 2005 | 191 | 2005 |
| Mechanisms of cellular communication through intercellular protein transfer KA Ahmed, J Xiang Journal of cellular and molecular medicine 15 (7), 1458-1473, 2011 | 176 | 2011 |
| Dendritic cell-derived exosomes stimulate stronger CD8+ CTL responses and antitumor immunity than tumor cell-derived exosomes S Hao, O Bai, J Yuan, M Qureshi, J Xiang Cell Mol Immunol 3 (3), 205-211, 2006 | 170 | 2006 |
| Membrane‐bound HSP70‐engineered myeloma cell‐derived exosomes stimulate more efficient CD8+ CTL‐ and NK‐mediated antitumour immunity than … Y Xie, O Bai, H Zhang, J Yuan, S Zong, R Chibbar, K Slattery, M Qureshi, ... Journal of cellular and molecular medicine 14 (11), 2655-2666, 2010 | 164 | 2010 |
| CD4+ T cell-released exosomes inhibit CD8+ cytotoxic T-lymphocyte responses and antitumor immunity H Zhang, Y Xie, W Li, R Chibbar, S Xiong, J Xiang Cellular & molecular immunology 8 (1), 23-30, 2011 | 147 | 2011 |
| Intercellular trogocytosis plays an important role in modulation of immune responses KA Ahmed, MA Munegowda, Y Xie, J Xiang Cellular & molecular immunology 5 (4), 261-269, 2008 | 142 | 2008 |
| Dendritic cells recruit T cell exosomes via exosomal LFA-1 leading to inhibition of CD8+ CTL responses through downregulation of peptide/MHC class I and Fas ligand-mediated … Y Xie, H Zhang, W Li, Y Deng, MA Munegowda, R Chibbar, M Qureshi, ... The Journal of Immunology 185 (9), 5268-5278, 2010 | 141 | 2010 |
| Epigenetic transfer of metastatic activity by uptake of highly metastatic B16 melanoma cell-released exosomes. S Hao, Z Ye, F Li, Q Meng, M Qureshi, J Yang, J Xiang Experimental oncology 28 (2), 126-131, 2006 | 138 | 2006 |
| Aptamer-functionalized nanoparticles in targeted delivery and cancer therapy Z Fu, J Xiang International Journal of Molecular Sciences 21 (23), 9123, 2020 | 126 | 2020 |
| Th17 and Th17-stimulated CD8+ T cells play a distinct role in Th17-induced preventive and therapeutic antitumor immunity M Ankathatti Munegowda, Y Deng, SJ Mulligan, J Xiang Cancer Immunology, Immunotherapy 60, 1473-1484, 2011 | 125 | 2011 |
| CD4+ Th1 cells promote CD8+ Tc1 cell survival, memory response, tumor localization and therapy by targeted delivery of interleukin 2 via acquired pMHC I … H Huang, S Hao, F Li, Z Ye, J Yang, J Xiang Immunology 120 (2), 148-159, 2007 | 112 | 2007 |
| IFN-γ down-regulates ABCA1 expression by inhibiting LXRα in a JAK/STAT signaling pathway-dependent manner X Hao, D Cao, Y Hu, X Li, X Liu, J Xiao, D Liao, J Xiang, C Tang Atherosclerosis 203 (2), 417-428, 2009 | 108 | 2009 |
| CD4− 8− dendritic cells prime CD4+ T regulatory 1 cells to suppress antitumor immunity X Zhang, H Huang, J Yuan, D Sun, WS Hou, J Gordon, J Xiang The Journal of Immunology 175 (5), 2931-2937, 2005 | 106 | 2005 |
| Advances in dendritic cell-based vaccine of cancer X Zhang, JR Gordon, J Xiang Cancer Biotherapy and Radiopharmaceuticals 17 (6), 601-619, 2002 | 106 | 2002 |
| Aptamers, the nucleic acid antibodies, in cancer therapy Z Fu, J Xiang Advances in Medical Biochemistry, Genomics, Physiology, and Pathology, 143-175, 2021 | 104 | 2021 |
| One Hundred Seventy-Fold Increase in Excretion of an FV Fragment-Tumor Necrosis Factor Alpha Fusion Protein (sFV/TNF-α) fromEscherichia coli Caused by the … J Yang, T Moyana, S MacKenzie, Q Xia, J Xiang Applied and environmental microbiology 64 (8), 2869-2874, 1998 | 104 | 1998 |
| Lymphotactin expression by engineered myeloma cells drives tumor regression: mediation by CD4+ and CD8+ T cells and neutrophils expressing XCR1 receptor CM Cairns, JR Gordon, F Li, ME Baca-Estrada, T Moyana, J Xiang The Journal of Immunology 167 (1), 57-65, 2001 | 103 | 2001 |
